Do you have info to share with HuffPost reporters? Here’s how.
All the major features of Purdue's handling of OxyContin conform to similar acts of corporate fraud perpetrated in recent years. Still the story is peculiar in some key respects. Many times corporate fraud originates in some fairly innocent business model. Not so with OxyContin, a dubious affair from the start.